Tylenol use in pregnancy may be linked with uterus, ovary changes in daughters
Female reproductive organ development may be impacted by a mother's use during pregnancy of Tylenol or its generic versions, according to researchers who emphasize that their study does not prove the pain medicine is to blame and does not indicate any effect on future fertility. Whether the differences observed in the Danish study of infants have implications for fertility later in life and age…
A study suggests that using Tylenol during pregnancy may be linked with changes in a daughter's uterus and ovaries, but researchers stress their findings do not prove the pain medication is the cause and do not impact future fertility. Lead researcher Margit Bistrup Fischer of Rigshospitalet in Copenhagen said more long-term follow-up is needed to determine the implications for fertility later in life and age at menopause.
Pregnant women using the generic version of Tylenol, paracetamol in Europe, should not be alarmed by the findings, Fischer added. Kenvue, owner of the Tylenol brand, advises pregnant or breastfeeding women to consult a healthcare professional before using acetaminophen, the generic name for Tylenol, which is considered the most studied and safest pain reliever during pregnancy.
The study has limitations in methodology and does not support a causal relationship between Tylenol use and reproductive organ development in daughters.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
